Genky DrugStores Co., Ltd. (9267.T) Comparison with companies in other sectors?

Genky DrugStores Co., Ltd. has a share price of 30.40M. You can analyze Genky DrugStores Co., Ltd. (9267.T) competitors across different market sectors through stock heatmaps.

What are 9267.T's NET and operating margins?

Genky DrugStores Co., Ltd. (9267.T) operating margin is around 0.05, and net profit margin is approximately 0.03 as of the latest reports.

In what way does 9267.T's earnings per share (EPS) trend reflect its financial momentum?

Genky DrugStores Co., Ltd. (9267.T) EPS is 231.88 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Genky DrugStores Co., Ltd. is 19.86, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Genky DrugStores Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Genky DrugStores Co., Ltd. like P/E which is 20.76, P/B which is 2.73, and PEG which is 5.75. Compare them with sector averages to evaluate if the stock is priced fairly.

Genky DrugStores Co., Ltd.

9267.T•JPX

Healthcare

Medical - Pharmaceuticals

¥4605.00

¥85.00(1.88%)

Genky DrugStores Co., Ltd. (9267.T) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$231.88

P/E Ratio

19.86

ROE

0.14%

Net Margin

0.03%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$139.97B

Shares OutstandingTotal number of shares issued

$30.40M

Book Value/ShareNet worth per share

$1684.89

Revenue/ShareAnnual revenue per share

$6436.90

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$231.88

Net MarginNet income as percentage of revenue

3.45%

Operating MarginOperating income as percentage of revenue

4.79%

ROEReturn on shareholders' equity

13.77%

ROAReturn on total assets

5.30%

ROCEReturn on capital employed

11.57%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$395.87

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$13.00

Dividend YieldAnnual dividend as percentage of stock price

0.28%

Financial Ratios Analysis data is not available for 9267.TFinancial Ratios Analysis details for 9267.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 9267.TSector Benchmarking details for 9267.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Genky DrugStores Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Genky DrugStores Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Genky DrugStores Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for Genky DrugStores Co., Ltd.

For Genky DrugStores Co., Ltd., essential financial indicators include EPS 231.88, PE 19.86, and ROE 0.14. These key ratios reveal insights into Genky DrugStores Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Genky DrugStores Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Genky DrugStores Co., Ltd.

Metrics like Net Margin 3.45% and ROA 5.30% shed light on how well Genky DrugStores Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Genky DrugStores Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of Genky DrugStores Co., Ltd.

Using ratios such as P/B Ratio 2.73 and PEG Ratio 5.75, investors can assess whether Genky DrugStores Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with Genky DrugStores Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Genky DrugStores Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.67 and Cash Flow -, provide a snapshot of Genky DrugStores Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Genky DrugStores Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Genky DrugStores Co., Ltd.

Investing in Genky DrugStores Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Genky DrugStores Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;